Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Seaforth ...
You can't just split the shares. Where would the shares come from that are given to the TPL owners? In order to do what you are saying, all the current ptsc shareholders would have to give up half of their shares so that they could be given to the TPL owners. In which case, yes, the price per share would double, but you would only have half the shares you previously had (same overall value).
Share
New Message
Please login to post a reply